A USstudy found thatcombiningimmunotherapywithchemotherapybeforesurgeryhelped patientswithlocallyadvancedlungcancer. In the trial, 81%ofpatientscouldundergosurgeryafterthiscombinedtreatment, andallpatientssurvivedatleast1.5years.